The Cooper Companies, Inc. (COO) Average EV/Assets Ratio
The current ev/assets ratio for The Cooper Companies, Inc. (COO) is 1.25x as of Sunday, June 14, 2026, shown against its trailing averages.
Average EV/Assets Ratio Chart
COO EV/Assets Ratio Averages
EV/ASSETS RATIO CURRENT
1.25x
EV/ASSETS RATIO TTM
1.36x
EV/ASSETS RATIO 3Y
1.62x
EV/ASSETS RATIO 5Y
1.75x
EV/ASSETS RATIO 10Y
2.15x
EV/ASSETS RATIO 15Y
2.09x
EV/ASSETS RATIO 20Y
1.84x
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White